GINNA GRANROTH: Open Payments
NPI 1477980092 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65,225 in 172 payments from 16 companies in 2025. Trend: 2023 $32,261 · 2024 $55,411 · 2025 $65,225
Speaker / faculty: $44,920Travel & lodging: $13,768Food & beverage: $4,784Consulting: $1,683Education: $70
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 46 | $18,075 |
| E.R. Squibb & Sons, L.L.C. | 30 | $15,101 |
| Incyte Corporation | 36 | $13,345 |
| SOBI, INC | 20 | $12,045 |
| Genmab U.S., Inc. | 6 | $3,024 |
| ABBVIE INC. | 7 | $2,662 |
| Celgene Corporation | 13 | $221 |
| GlaxoSmithKline, LLC. | 1 | $178 |
| Fennec Pharmaceuticals, Inc. | 1 | $146 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
Products named: BREYANZI, Yescarta, Vonjo, Jakafi, Epkinly, Niktimvo, OJJAARA, Fyarro.
Industry payments across AZ — which companies pay providers there.
